Preliminary Analysis of the Cost-Effectiveness of Pertuzmab in Patients with Her2-Positive Breast Cancer in Japan
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.113
https://www.valueinhealthjournal.com/article/S1098-3015(18)32470-7/fulltext
Title :
Preliminary Analysis of the Cost-Effectiveness of Pertuzmab in Patients with Her2-Positive Breast Cancer in Japan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32470-7&doi=10.1016/j.jval.2018.07.113
First page :
Section Title :
Open access? :
No
Section Order :
122